Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-28

FDA Approved: GANIRELIX ACETATE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA, LLC's original application for ganirelix acetate, a GnRH antagonist used to prevent premature LH surge during controlled ov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix acetate (ganirelix acetate)

Snippet

ORIG AP for GANIRELIX ACETATE (GANIRELIX ACETATE)